Friday, June 24, 2016 11:37:41 AM
Poster Session B
Monday, June 27, 2016 5:00 p.m.–7:00 p.m.
Galleria Hall
B26 A novel applicator for endoscopic gene electrotransfer. Arya Bahrami, Oncosec Medical Inc., San Diego, CA, United States.
B32 Feedback optimized gene electrotransfer for immunotherapy. Richard Connolly, OncoSec Medical Inc., San Diego, CA, United States.
www.aacr.org/Documents/EPSO16_Poster%20B%20for%20Web.pdf
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM